Showing results (1431-1440 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|April 11, 2012
Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. a single institution survey spanning 1998 to 2010A García Fernández, N Giménez, M Fraile, et al.Breast (Edinburgh, Scotland)|April 24, 2012
Metastatic breast cancer: we do need primary cost dataJ Bonastre, P Jan, Y Barthe, et al.Breast (Edinburgh, Scotland)|October 7, 2014
Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodesAntonio Piñero-Madrona, Guadalupe Ruiz-Merino, Laia Bernet, et al.Breast (Edinburgh, Scotland)|October 11, 2014
Patient participation in multidisciplinary tumor conferencesLena Ansmann, Christoph Kowalski, Holger Pfaff, et al.Breast (Edinburgh, Scotland)|October 12, 2014
Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgeryN Biglia, R Ponzone, V E Bounous, et al.Breast (Edinburgh, Scotland)|October 15, 2014
Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancerElsa Dalmau, Alejandra Armengol-Alonso, Montserrat Muñoz, et al.Breast (Edinburgh, Scotland)|September 18, 2014
Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive casesC G Kryh, C A Pietersen, H B Rahr, et al.Breast (Edinburgh, Scotland)|August 2, 2014
Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled studyL Aerts, M R Christiaens, P Enzlin, et al.Breast (Edinburgh, Scotland)|August 5, 2014
Ovarian function preservation with GnRH agonist in young breast cancer patients: does it impede the effect of adjuvant chemotherapy?Jiyoung Kim, Minkook Kim, Jun Ho Lee, et al.Breast (Edinburgh, Scotland)|July 16, 2014
Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysisH Staley, I McCallum, J BrucePageof 366